Role of Calprotectin in Human Health and Disease
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 4516
Special Issue Editors
Interests: anesthesiology; biomarkers; calprotectin; coagulation; cytokines; endotoxin; critical care medicine; inflammation; intensive care; intraosseous; leptin; point-of-care; SAPS3; sepsis; shock
Special Issues, Collections and Topics in MDPI journals
Interests: endotoxin; Intensive Care; acute kidney injury; glomerular filtration rate markers; kidney tubular damage markers; cardiovascular risk markers; neutrophil activation markers; calprotectin
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
You are invited to contribute research on calprotectin, a pleiotropic molecule released in both acute and chronic inflammation, is a heterodimer of two mammalian calcium-binding proteins and is released from the cytoplasm of neutrophil granulocytes upon their activation. Calprotectin (S100A9/S100A8) is a member of the S100 protein family. Calprotectin, as a proinflammatory factor of innate immunity, is related to the endogenous damage-associated molecular pattern (DAMP) molecule via Toll-like receptor 4 activation.
Determination of calprotectin is a valuable clinical biomarker of inflammation. In inflammatory gastro-intestinal diseases, colonoscopy and histopathologic evaluation of bowel biopsy specimens are usually regarded as the gold standards for diagnosis and management of such diseases. However, colonoscopy and colon biopsy are not only costly, but occasionally associated with complications. Since fecal calprotectin may serve as a potential surrogate marker for colonoscopy, several clinical studies have focused on this issue. Furthermore, calprotectin may serve as a biomarker of disease activity in rheumatoid arthritis. Plasma calprotectin seems to be a promising biomarker in respiratory infections, allowing more precise diagnosis and selective use of antibiotics compared to other biomarkers. In critically ill patients with bacterial infections, plasma calprotectin seems to be a useful biomarker. Based on these findings, a health economic analysis of the predictive use of plasma calprotectin indicates that this biomarker has cost-saving and life-saving impacts. Calprotectin may rapidly be analyzed turbidimetrically.
Dr. Mats B. Eriksson
Prof. Dr. Anders O. Larsson
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- acute phase reactants
- analysis
- bacterial infection
- biomarker
- calprotectin
- critical care
- inflammation
- turbidimetric
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
